ArticlePloS one2025
Association between methylmalonic acid and Alpha-Klotho in American adults: A cross-sectional study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesMethylmalonic acid is a surrogate biomarker of mitochondrial dysfunction and oxidative stress. Serum soluble α-Klotho, as a key anti-aging factor, is regarded as one of the biomarkers of aging. The correlation between Methylmalonic Acid (MMA) and Alpha-Klotho (α-Klotho) remains uncertain. This study aims to explore the relationship between MMA and Alpha-Klothoα-Klotho in American adults. MATERIALS AND
methodsBased on the availability of complete biochemical assays for MMA and α-Klotho, we restricted our analyses to the 2011-2014 cycles of the National Health and Nutrition Examination Survey (NHANES), which included 5,216 eligible participants with comprehensive laboratory data. Due to the limited amount of data, there may be a selection bias. In this study, MMA serves as the independent variable while α-Klotho functions as the dependent variable. MMA is a categorical variable, while α-Klotho is a categorical variable. The covariates examined include sociodemographic factors, lifestyle choices, and various systemic diseases. Logistic regression was used to assess the associations between covariates and different independent groups. To explore the relationship between serum MMA levels and α-Klotho, we employed three models: Model 1 adjusted for age, gender, race/ethnicity, education, Marital status, Poverty Income Ratio (PIR), smoking, Body Mass Index (BMI) and Physical activity (PA). Model 2 included all variables from Model 1 plus Cardiovascular diseases (CVD), Hypertension, Diabetes Mellitus (DM). Considering the collinearity problem, Model 3 adjusted for Marital status, PIR, Educations, Smoke, PA, CVD, Hypertension, DM, Glycated Hemoglobin A1c (HbA1c), High-Density Lipoprotein (HDL), Vitamin B12 (VitB12), Estimated Glomerular Filtration Rate (eGFR).
resultsA total of 5216 participants were included in the study. Among them, 29.4% (1531 participants) had α-Klotho levels below 704.00 pg/mL, while 70.6% (3685 participants) had levels of 704 pg/mL or greater. Compared to individuals with low serum MMA levels Q1 (<120 nmol/L), the adjusted odds ratios (OR) for α-Klotho with MMA levels in Q2 (120-175 nmol/L), Q3 (175-250 nmol/L), and Q4 (≥250 nmol/L) were 0.81 (95% CI: 0.72 to 0.91, p = 0.001), 0.81 (95% CI: 0.71 to 0.93, p = 0.003), and 0.80 (95% CI: 0.68 to 0.94, p = 0.007), respectively.The correlation between MMA levels and α-Klotho was linearly correlated (non-linearity: P = 0.62).
conclusionOur findings indicate a significant association between higher MMA levels and lower serum α-Klotho concentrations, It suggests that mitochondrial dysfunction may play a significant role in the aging process. Further research is necessary to validate these findings. This relationship warrants further investigation to clarify its implications for aging and health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.